Healthy Heart. Management of Left Main Coronary Artery Disease. From the desk of Editor: Figure 1. Price : ` 5/- Volume-5 Issue-51 February 5, 2014
|
|
- Silvia Green
- 5 years ago
- Views:
Transcription
1 Healthy Honorary Editor : Dr. Urmil Shah From the desk of Editor: Newer technology and research is the key to field of medicine including cardiology. In this issue of Healthy two topics covered are classic example of how newer innovation is helping doctors to manage their patient in a better way day by day. When I was doing my DM residency absolute indication of CABG was patient with left main disease but in 2014 with availability of newer hardware and technology the whole concept of managing left main disease is changed. Patient with stable coronary artery disease where anatomical information about coronary artery blockage which is obtained by conventional coronary angiography with known limitation of physiological imaging techniques; interventional management in this subset of patients does create many doubts and discrepancy. A simple diagnostic technique with name of Fractional Flow eserve (FF) and Intravascular Ultrasound (IVUS) is very useful in decision making regarding intervention in many patients. - Dr. Urmil Shah urmil.shah@cims.me Price : ` 5/- Management of Left Main Coronary Artery Disease The third case of Angioplasty in the world done by Dr. Andreas Gruentzig in 1977 was left main stenting. Patient died after 4 month of procedure a time of No Drug Eluting Stent, No Antiplatelets, No IVUS. CASS(Coronary Artery Surgery Study) study shown significant better outcome of CABG compare to medical arm. Since then for many years, CABG has been main stay for treatment of left main disease. Due to improvement in technology and availability of new generation drug eluting stent many of the patients with left main disease can be managed with good midterm outcome compared to CABG. Patients with left main disease who have already undergone CABG with one graft patent (Protected Left Main) is always m a n a g e d w i t h i n t e r v e n t i o n. Management of unprotected left main disease (without previous CABG) will be discussed in this article. Left main disease can be classified into isolated left main disease (approximately 15%), left main with 1 vessel, 2 vessel and 3 vessel disease. Left main disease can also be classified according to location of lesion to ostial, mid and distal left main disease. There is great limitation of conventional angiography for diagnosis and managing left main disease. Intra Vascular Ultra Sound (IVUS) and Fractional Flow eserve (FF) are very important in deciding Figure 1 Cardiologists Cardiothoracic & Vascular Surgeons Cardiac Anaesthetists Dr. Ajay Naik (M) Dr. Milan Chag (M) Dr. Dhiren Shah (M) Dr. Niren Bhavsar (M) Dr. Satya Gupta (M) Dr. Urmil Shah (M) Dr. Dhaval Naik (M) Dr. Hiren Dholakia (M) Dr. Chintan Sheth (M) Dr. Vineet Sankhla (M) Dr. Hemang Baxi (M) Dr. Saurabh Jaiswal (M) Neonatologist and Pediatric Intensivist Dr. Gunvant Patel (M) Dr. Anish Chandarana (M) Pediatric & Structural Surgeons Dr. Amit Chitaliya (M) Dr. Shaunak Shah (M) Dr. Keyur Parikh (M) Cardiac Electrophysiologist Pediatric Cardiologists Vascular & Endovascular Surgeon Dr. Ajay Naik (M) Dr. Kashyap Sheth (M) Dr. Milan Chag (M) Dr. Srujal Shah (M) Dr. Vineet Sankhla (M)
2 Healthy severity of lesion. IVUS is mandatory pre and post to decide stent size and post stents opposition to vessel wall. The aim of any intervention including left main intervention should be good immediate success with acceptable risk as well as good long term outcome. Many factors are important both clinical and anatomical like presentation, age of the patients, LV function, risk of bleeding, long term out come data,cost, patients preference, availability of skilled operator and well equipped center to recommend line of management. For choosing CABG and angioplasty, syntax score based on Angiography is very helpful. With syntax score less then 33 mid term outcome (5 to 6 years) for CABG and stenting with first generation drug eluting stent is same as shown in syntax study and also in meta-analysis, so angioplasty should be offered. For >33 syntax score, CABG is better than angioplasty and should be offered (Figure - 1). Clinical syntax score and global risk score which includes clinical and biochemical parameters can be of additional value in deciding line of management. New ongoing trial EXCEL study with new third generation DES (Xience) with syntax score <33 may give better guidance for choosing between CABG Vs. Angioplasty. Figure 2. Distal Left Main Lesion Management Ostial or mid left main disease is manged with single drug eluting stents of main vessel with provisional stenting of other branch, where as distal bifurcation lesion is managed with two stents using either mini CUSH or CULOTTE(Figure - 2). Plasty is done through femoral route and pre and post angioplasty IVUS by experience person is pre requisite in left main intervention. European guide line published in 2013 as shown in figure below will give a clear idea for managing stable left main disease (Figure - 3). It is advocated to discuss all left main cases with multi vessel disease with heart surgical team and surgical risk should also be taken into account before recommending patient with left main disease. In conclusion, my current opinion in decision making would be CABG for left main disease with syntax score >33 if CABG is not contraindicated or predicted risk of CABG <10 %. With syntax score <33 Angioplasty with drug eluting stent with IVUS is recommended except technically difficult lesion CF, diabetes. Figure
3 Healthy FF & IVUS - Diagnostic Techniques (Useful Adjuvant to Coronary Angiography) Though coronary angiography (CAG) is considered to be gold standard for diagnosis and management of Coronary Artery Disease over years, there are several definite limitations. In patients with acute coronary syndrome, coronary angiography still can give definitive line of management as far as intervention is concerned with help of clinical parameter, ECG and bio marker. But in stable angina patient there are many doubts, controversies and discrepancies regarding definitive interventional management with help of only coronary angiography as it gives more of a anatomical information and not physiological information. Non invasive test like thallium scan, stress test, stress echo done to know evidence of ischemia in patient with stable angina especially with left main disease, multi vessel disease, lesion of intermediate severity (50 to 70 %), LBBB, with LV dysfunction has several limitations. One has to be reasonably sure leaving this kind of patient on medical management; at the same time one should not be not doing intervention on patients which is not g o i n g t o b e n e f i t t h e p a t i e n t. Physiological assessment of lesion especially of intermediate severity and left main with the help of FF (simple pressure wire which measures pressure difference across the lesion with maximum hyperemia with adenosin) has been found to be very helpful in decision Figure-1 : FF is a technique to assess the functional significance of a coronary stenosis. FF is independent of changes in heart rate, blood pressure or prior infraction, and takes into account the amount of viable myocardium and the contribution of collateral blood flow. making along with coronary angiography inside Cath Lab. DEFFE study showed that deferring angioplasty in a patient with insignificant lesion (FF more than 0.8) has same incidence of MI and death at the end of 5 years and so can be considered safe in the long run. Deferring angioplasty helps to reduce the cost to the patient and reducing extra risk of the intervention. FAME-1 (FF v s. A n g i o g r a p h y i n Multivessel Evaluation) study of 1000 patient with multi vessel disease was conducted for FF guided (with FF < 0.8) angioplasty over only angiography guided angioplasty were studied. FF guided intervention was associated with 39 % less incidence of death MI and repeat procedure with less need of stent, hardware, dye. Thus FF guided therapy was not only cost effective but cost saving. ecently published FAME-2 study clearly demonstrated that patient with FF < 0.8 (physiologically significant lesion) doing (Figure-2) 3
4 Healthy angioplasty is better than medical arm in long run as it reduces the future urgent need of revascularization. Thus FF avoids needs of intervention resources and cost to the patient at the same time improves quality of life and improves outcome in the long run. If one includes extra cost of urgent revascularization and outcome one can say that using FF along with angiography in patient with stable angina is not safe but cost effective also. In patient with multi vessel disease decision regarding which vessel should be stented is best done with FF which is lesion specific where stress thallium and stress echo is of limited value. This is the reason why FF is class-iia indication according to AHA/ACC 2011 guideline in patient with intermediate lesion (50 to 70 %) unstable angina not having symptom and positive non invasive imaging. European PCI guideline 2013 classified FF as class-i A indication for detection of ischemia related to lesion where objective evidence of ischemia is not available. 4 (Figure-3) Intravascular ultrasound (IVUS) as it gives more precise information regarding vessel size and composition of plaque is very much essential while doing complex interventions like left main disease, bifurcation disease, calcific disease. The reason for early stent thrombosis a potentially dangerous complication is partly because of under expansion of stent where IVUS has an important role. (Figure-5) (Figure-6) Mata-analysis of various CTs of IVUS Guided vs Angio Guided BMS and drug eluting stents implantation clearly showed better outcome in form of overall MACE (Major Adverse Cardiac Events), angiography restenosis less stent thrombosis with IVUS guided Angioplasty. Thus FF is very useful adjuvant to conventional agniography and is considered as gold standard in dealing with stable angina patient with inter mediate lesion (50 to 70 % lesion) and in patient with multi vessel disease as it improves MACE. Whereas IVUS is essential to improve outcome and reduce complication in complex coronary intervention. (Figure-4) (Figure-7)
5 Healthy Hospital, Ahmedabad In Association with Gujarat Cardiothoracic Surgeons Club JIC 2014 Joint International Conference Ahmedabad Aortic Conclave (AAC) Around 200 Cardiac Surgeons & Anaesthetists attended the conference First of its kind live workshop on Aortic valve repair in India First of its kind Cardiac conference in India to be live webcasted all over the world First of its kind of conference to have wetlab for new and aspiring cardiac surgeons who get guidance from expert from the field of Aortic Surgery Video Launch of a very new techologically advanced Aortic sutureless valve in India Cardiothoracic & Vascular Surgeons Dr. Dhiren Shah Dr. Dhaval Naik Dr. Saurabh Jaiswal Pediatric & Structural Surgeon Dr. Shaunak Shah Vascular & Endovascular Surgeon Dr. Srujal Shah Cardiac Anaesthetists Dr. Niren Bhavsar Dr. Hiren Dholakia Dr. Chintan Sheth Thoracic & Thoracoscopic Surgeon Dr. Pranav Modi Congratulations to Dr. Hemang Baxi and Dr. Vineet Sankhla for receiving the prestigious FESC (Fellowship of European Society of Cardiology) Award HOSPITAL CONGATULATES D. KEYU PAIKH AAPI GLOBAL LEADESHIP AWAD AT THE HANDS OF HONOABLE CHIEF MINISTE Hon ble Shri NAENDA MODI Dr. Hemang Baxi Dr. Vineet Sankhla 5
6 Healthy We bring in among the first in World adiotherapy Versa-HD (Elekta) in Asia Pacific Dr. Devang C. Bhavsar MD (M) Consultant adiation Oncologist at Cancer Center. Associate Professor and post graduate teacher at Gujarat Cancer & esearch Center. One of the pioneers of Image Guided adiotherapy technique in India. Special interest in Neuro Oncology, Prostate Cancers & SS. Very active in social activities like cancer awareness camps. Linear Accelerator, Versa HD To complete its offer of a super multispecialty hospital, is proud to offer a new service, by introducing adiation Oncology Center. This upcoming set up is all geared up to be open to service by end of March Uniqueness of adiation Centre n First Versa HD Linear Accelerator by Elekta in Asia n Agility- High focus 160 leaf MLC, newly launched by Elekta n APEX DMLC - A High definition 2.5mm leaf width for brain tumors n First FFF mode treatment in Asia by Elekta n 3 times higher dose rate than any other normal Linac dose rate n Hexapod-6 dimensional motion correction by robotic couch n Minimize the treatment setup error by correcting 3 rotational & 3 transverse motions during the treatment. n Active Breathing Coordinator System q Exactly track the position of moving target like lung tumor because of breathing motion & reduce the dose to normal tissue. n 4D SYMMETY q SymmetryTM provides acquisition and in line reconstruction of 4D volumetric data, utilizing unique patented technology for sorting each projection image into a phase based bin. This sorting occurs by reviewing the moving anatomy within the projection images and calculating a respiratory trace directly from the internal anatomy Dr. Kinjal. Jani MD (M) Consultant adiation Oncologist at Cancer Center. Gold medalist for subject ENT in MBBS. eceived the first rank award from Gujarat Cancer Society in One of the highest experience of Image Guided adiotherapy in India. Special interests in Head & Neck Oncology, Prostate Cancers & Breast Cancers. Very active in social activities like cancer awareness talks and camps. Equipped with the latest state-of-the art equipment and supported by highly qualified and dedicated oncologists, Care Institute of Medical Sciences is all set to become one of the desired destinations of cancer patients from across the country and specifically catering to the population of Western India. 6
7 Healthy JIC 2015 Joint International Conference January 9-11, 2015 SUPE EALY BID EGISTATION Cheque or DD's to be made A/C payee and in the name of Hospital Pvt. Ltd. Kindly mail the registration form along with the cheque/dd to our office. All Cash Payment are to be made at Hospital, Ahmedabad' only. Please note that it is mandatory to provide all the information. Please fill in all fields in CAPITAL LETTES Full Name Qualification esi. Address GMES Medical College, Sola, Ahmedabad Organized by E Care Institute Medical Society for esearch and Education Book your dates Special Discounted egistration ` 2,500/- only* *till March 31, 2014 From April 1, 2014 egistration Fees will be ` 5,000/- JIC 2015 egistration Form Phone (STD code) City Mobile Pin Code Payment Details ` ` in word : DD/Cheque No. Date Bank : GMES Medical College, Sola, Ahmedabad Organized by E Care Institute Medical Society for esearch and Education Signature : Conference Secretariat Hospital, Nr. Shukan Mall, Off Science City oad, Sola, Ahmedabad Phone : / 1060 Fax: communication@cimshospital.org, 7
8 Healthy Healthy egistered under NI No. GUJENG/2008/28043 th Published on 5 of every month th th Permitted to post at PSO, Ahmedabad on the 12 to 17 of every month under st Postal egistration No. GAMC-1725/ issued by SSP Ahmedabad valid upto 31 December, 2014 th Licence to Post Without Prepayment No. CPMG/GJ/97/2012 valid upto 30 June, 2014 If undelivered Please eturn to : Hospital, Nr. Shukan Mall, Off Science City oad, Sola, Ahmedabad Ph. : (5 lines) Fax: Mobile : , Subscribe Healthy : Get your Healthy, the information of the latest medical updates only ` 60/- for one year. To subscribe pay ` 60/- in cash or cheque/dd at Hospital Pvt. Ltd. Nr. Shukan Mall, Off Science City oad, Sola, Ahmedabad Phone : / Cheque/DD should be in the name of : Hospital Pvt. Ltd. Please provide your complete postal address with pincode, phone, mobile and id along with your subscription JIC 2014 We thank the medical fraternity for the over whelming response to JIC 2014 Joint International Conference JIC 2014 : A great academic attraction for all physicians Please visit our website and review JIC Daily (Newsletter) & Abstract Book 8 Printed, Published and Edited by Dr. Keyur Parikh on behalf of the Hospital Printed at Hari Om Printery, 15/1, Nagori Estate, Opp. E.S.I. Dispensary, Dudheshwar oad, Ahmedabad Published from Hospital, Nr. Shukan Mall, Off Science City oad, Sola, Ahmedabad
INTRODUCTION AND SALIENT FEATURES:
Price : ` 5/- Honorary Editor : Dr. Milan Chag From e desk of Honorary Editor: Percutaneous Transluminal myocardial septal ablation (PTSMA) has emerged as a less invasive treatment of symptomatic patients
More informationrise to the left anterior descending (LAD) and left circumflex (LCX) arteries, and probably an intermedius artery.
Heart Price : ` 5/- Honorary Editor : Left Main wi Multi Vessel PCI (in Case of Seropositive Illness wi Thrombocytopenia) Dr. Keyur Parikh Dr. Vipul Kapoor From e Desk of Hon. Editor: Considering lesion
More informationHealthy Heart. PCSK9 INHIBITION : New Therapies in Cardiovascular Risk Reduction. From the Desk of Hon. Editor: Price : ` 5/-
Healthy Price : ` 5/- Honorary Editor : Dr. Urmil Shah PCSK9 INHIBITION : New Therapies in Cardiovascular isk eduction From the Desk of Hon. Editor: Dear Friends, Elevated LDL cholesterol remains an important
More informationHealthy Heart CIMSR. Isolated Systolic Hypertension. Care Institute of Medical Sciences. Volume-3 Issue-30 May 5, Price : ` 5/- Case History
R Price : ` 5/- Honorary Editor : Dr. Hemang Baxi Cardiologists Dr. Anish Chandarana (M) +91-98250 96922 Dr. Ajay Naik (M) +91-98250 82666 Dr. Satya Gupta (M) +91-99250 45780 Dr. Joyal Shah (M) +91-98253
More informationHealthy Heart CIMSR. Electrocardiology and Electrophysiology: Tools of the Trade. Care Institute of Medical Sciences. Volume-2 Issue-16 March 5, 2011
CIMSR Price : Rs. 5/- Honorary Editor : Dr. Ajay Naik Cardiologists Dr. Anish Chandarana (M) +91-98250 96922 Dr. Ajay Naik (M) +91-98250 82666 Dr. Satya Gupta (M) +91-99250 45780 Dr. Gunvant Patel (M)
More informationHEALTHY HEART. First ever two Heart Valve Replacements in Gujarat (without open surgery) using the New Revolutionary Technology TAVI
VOLUME-10 ISSUE-113 APRIL 05, 2019 First ever two Heart Valve Replacements in Gujarat (without open surgery) using the New Revolutionary Technology TAVI PARADIGM SHIFT IN HEART VALVE TREATMENT IN THE 21ST
More informationBenefit of Performing PCI Based on FFR
Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided
More informationFractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center
Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationEvaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013
Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart
More informationFractional Flow Reserve. A physiological approach to guide complex interventions
Fractional Flow Reserve A physiological approach to guide complex interventions What is FFR? Fractional Flow Reserve (FFR) is a lesion specific, physiological index determining the hemodynamic severity
More informationPCIs on Intermediate Lesions NCDR Cath-PCI Registry
Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further
More informationFFR Incorporating & Expanding it s use in Clinical Practice
FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel
More informationhigh SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy
What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy Who are the patients with high SYNTAX
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationEvolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands
Evolution In Interventional Cardiology Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands 25 November 2010 Coronary Atherosclerosis Timeline in interventional cardiology Indications for
More informationFFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium
FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationDebate Should we use FFR? I will say NO.
Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea
More informationUpgrade of Recommendation
Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for
More informationWhat do the guidelines say?
Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European
More informationZiyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut
Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Adjunct Professor Emory University School of Medicine Indication
More informationEXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017
EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts
More informationFractional Flow Reserve: Review of the latest data
Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most
More informationLeft Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD
Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationDave Kettles, St Dominics Hospital East London.
Dave Kettles, St Dominics Hospital East London. 110 x 150 Angina for a couple of months Trop T negative T wave inversion across the chest leads Not wanting to risk radial Huge struggle with femoral
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE
ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE Angioplasty Summit TCT ASIA Seoul, Korea, april 24th, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands A rather common
More informationFRACTIONAL FLOW RESERVE: STANDARD OF CARE
FRACTIONAL FLOW RESERVE: FROM INVESTIGATIONAL TOOL TO STANDARD OF CARE TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands FRACTIONAL FLOW
More informationPerspective of LM stenting with Current registry and Randomized Clinical Data
Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level
More informationINSIDE INFORMATION YOU CAN T IGNORE
INSIDE INFORMATION YOU CAN T IGNORE Volcano, the Volcano logo and SyncVision are registered trademarks of Volcano Corporation. All other trademarks set-forth are properties of their respective owners.
More informationFractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --
Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement -- JoonHyung Doh, MD, PhD Assistant Professor, Vision21 Cardiac and Vascular Center Inje University Ilsan Paik Hospital Goyang, Korea
More informationControversies in Cardiac Surgery
Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm
More informationCoronary stenting: the appropriate use of FFR
Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California Irvine Orange, California To treat or not
More informationLe# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement
More informationPatient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /
Patient Patient code Birth date: / / Sex: Male Height (cm): Female Weight (kg): Risk Factors: Family history of coronary disease: Hypertension Dyslipidemia Peripheral disease Diabetes Comorbidities: No
More informationFFR in Multivessel Disease
FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands
More informationThe major goal of therapy is to prevent. Incidence of stroke. Increases stroke risk by 340 % Without this condition With this condition
Honorary Editor : Dr. Milan Chag From the Desk of Hon. Editor: Dear Friends, Atrial Fibrillation (AF) is the most common arrhythmia in clinical practice affecting approximately 9 million people in US and
More informationAssessing Myocardium at Risk: Applying SYNTAX
Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program
More informationCCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30:
CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD Teo et al, Canadian Journal of Cardiology 2014;30: 1482-1491 Parallel Paper: Canadian Cardiovascular Society Guidelines for the Diagnosis
More informationTechnical Aspects and Clinical Indications of FFR
Technical Aspects and Clinical Indications of FFR Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst - OLV Clinic Aalst, Belgium Potential conflicts of interest Consulting fees and honoraria on
More informationPCI vs. CABG From BARI to Syntax, Is The Game Over?
PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease
More informationCASE from South Korea
CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke
More informationMost Patients with Elective Left Main Disease. Farrel Hellig
Most Patients with Elective Left Main Disease Should be Treated with PCI! Farrel Hellig Sunnnghill and Sunward Park Hospitals Johannesburg South Africa Everything that can be invented has been invented
More informationINTERVENTIONAL CARDIOLOGY (Dedicated Fellowship)
INTERVENTIONAL CARDIOLOGY (Dedicated Fellowship) Director: Dr. Edward O Leary Teaching Faculty: Drs. Edward O Leary, Gregory Pavlides and Yiannis Chatzizisis A. OBJECTIVES 1. Management of patients in
More informationFRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls
FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls Ahmed M ElGuindy, MSc, MRCP(UK) Division of Cardiology Aswan Heart Centre 2013 Fractional Flow Reserve Essential diagnostic tool
More informationWhy I try to avoid side branch dilatation
Why I try to avoid side branch dilatation Hyeon-Cheol Gwon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Why I don t kiss? I kiss! I prefer to discuss SB ballooning rather
More informationNational Intervention Council
National Intervention Council Cardiological Society of India Registry Performa for Coronary, Non- Coronary & Peripheral Interventions Period January 1st 2016 to December 31 st 2016 Dr. (Prof.) N.N. Khanna
More informationKurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report
World Journal of Cardiovascular Diseases, 2014, 4, 483-491 Published Online August 2014 in SciRes. http://www.scirp.org/journal/wjcd http://dx.doi.org/10.4236/wjcd.2014.49058 Kurdistan Technique for the
More informationLeft Main Intervention: Will it become standard of care?
Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,
More informationPCI for LMCA lesions A Review of latest guidelines and relevant evidence
HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd
More informationΣεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική
ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL
More informationLeft Main Intervention: Where are we in 2015?
Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa
More informationTiming of Surgery After Percutaneous Coronary Intervention
Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet
More informationLeft Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France
Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Background on LM stenosis 5% of patients undergoing angiography Of the myocardium 80% Bifurcation
More informationUnprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy
Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts
More informationPressure Wire Study. Fractional Flow Reserve (FFR) Nishat Jahagirdar Principal Clinical Cardiac Physiologist Kings College Hospital
Pressure Wire Study Fractional Flow Reserve (FFR) Nishat Jahagirdar Principal Clinical Cardiac Physiologist Kings College Hospital History Andreas Gruentzig s paper on Non operative dilation of coronaryartery
More informationSTENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy
STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on
More informationClinical case in perspective. Cases from Poland
Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationFAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS
Coronary Physiology In The Cathlab FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Educational Training Program ESC European Heart House april 7th 9th 2011 Nico H.J.Pijls, MD, PhD Catharina Hospital,
More informationR&M Solutions
PCI with DES versus CABG & syntax score Dr. Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology, Alexandria University, Egypt Head of Cardiology Department President of Egyptian Society of Cardiology
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationFractional Flow Reserve and the 1 Year Results of the FAME Study
Imaging and Physiology Summit Seoul, Korea, November 22, 2008 Fractional Flow Reserve and the 1 Year Results of the FAME Study William F. Fearon, M.D. Assistant Professor Division of Cardiovascular Medicine
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationSurgery Grand Rounds
Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000
More informationANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries
ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro
More informationFRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!
FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!! Juan Antonio Pastor-Cervantes,M.D FSCAI, FACC Cardiovascular Institute Memorial Regional Hospital Hollywood Florida
More informationPercutaneous Coronary Interventions Without On-site Cardiac Surgery
Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European
More informationTranscatheter Aortic Valve Implantation Procedure (TAVI)
Page 1 of 5 Procedure (TAVI) Introduction Aortic stenosis (AS) is a common heart valve problem associated with heart failure and death. Surgical valve repair or replacement is recommended if AS patients
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationHow to approach non-infarct related artery disease in patients with STEMI in a limited resource setting
How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting Ahmed A A Suliman, MBBS, FACP, FESC Associate Professor, University of Khartoum Interventional Cardiologist,
More informationFFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford
4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea FFR-Guided PCI William F. Fearon, M.D. Associate Professor Division of Cardiovascular Medicine University Medical Center Disclosure Statement
More informationNew Cardiac Technologies. Melva Meminger MSN, RN, CCRN
New Cardiac Technologies Melva Meminger MSN, RN, CCRN What s New in Cardiac Care? Bigger is not always better: the new smaller Loop recorders First we burned and now we freeze (sometimes!): Cryoablation
More informationin an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore
Unrelenting Left Main Disease in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Clinical History 72 years old Chinese lady Background and CV Risk
More informationMULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION
MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.
More informationInstantaneous Wave-Free Ratio
Instantaneous Wave-Free Ratio Alejandro Aquino MD Interventional Cardiology Fellow Washington University in St. Louis Barnes-Jewish Hospital Instantaneous Wave-Free Ratio Alejandro Aquino MD Disclosure
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationManagement of stable CAD FFR guided therapy: the new gold standard
Management of stable CAD FFR guided therapy: the new gold standard Suleiman Kharabsheh, MD Director; CCU, Telemetry and CHU Associate professor of Cardiology, Alfaisal Univ. KFHI - KFSHRC Should patients
More informationMid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators
Mid-term results from real-world REPARA registry Felipe Hernandez, on behalf of the REPARA investigators Potential conflicts of interest Speaker's name: Felipe Hernandez I have the following potential
More informationRay Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California
High Risk PCI Making Possible the Impossible Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California Disclosures Abiomed Research Support Consulting Agreement
More informationVCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital
VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital Complex PCI: Multivessel Disease George W. Vetrovec, MD. Kimmerling Chair of Cardiology VCU Pauley Heart Center Virginia
More information(EU), FACC (USA), FSCAI (USA)
How to reduce vascular complications of TAVI Paul TL Chiam MBBS (S pore), MMed, MRCP (UK), FAMS FRCP (Edin), FESC (EU), FACC (USA), FSCAI (USA) Cardiologist Mount Elizabeth Hospital Singapore Definition
More informationTCT mdbuyline.com Clinical Trial Results Summary
TCT 2012 Clinical Trial Results Summary FAME2 Trial: FFR (fractional flow reserve) guided PCI in all target lesions Patients with significant ischemia, randomized 1:1 Control arm: not hemodynamically significant
More informationFractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --
Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement -- Joon Hyung Doh, MD, PhD Associate Professor, Division of Cardiology Inje University Ilsan Paik Hospital Goyang, Korea 목차 Fractional
More informationAun-Yeong Chong MD, MRCP(UK), MBBS University of Ottawa Heart Institute
Aun-Yeong Chong MD, MRCP(UK), MBBS University of Ottawa Heart Institute Cardiac Imaging Symposium Oct 2013 Invasive Coronary Artery Assessment Coronary angiography IntraVascular UltraSound (IVUS) Optical
More informationBetween Coronary Angiography and Fractional Flow Reserve
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional
More information2010, Metzler Helfried
Perioperative Strategies in Patients on Dual Antiplatelet Drug Therapy: Noncardiac Surgery H. Metzler Department of Anaesthesiology and Intensive Care Medicine Medical University of Graz, Austria What
More informationAnatomy is Destiny, But Physiology is Here Today
Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue
More informationΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική
ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική X. ΓΡΑΪΔΗΣ Επεμβατικός καρδιολόγος, FSCAI Kλινική Euromedica-Κυανούς Σταυρός, Θεσσαλονίκη The Fear factor The two words LEFT MAIN
More informationONCOLOGY SYMPOSIUM JANUARY
JIC 2017 Joint International Conference th 13 Annual Scientific Symposium nd 22 Year of Academics ONCOLOGY SYMPOSIUM JANUARY 7-8, 2017 Venue : Hotel Hyatt, Vastrapur, Ahmedabad ORGANIZED BY GMERS Medical
More informationIntravascular Ultrasound
Scan for mobile link. Intravascular Ultrasound Intravascular ultrasound (IVUS) uses a transducer or probe to generate sound waves and produce pictures of the coronary arteries. IVUS can show the entire
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationAdvances in Cardiovascular Diagnosis and Therapy. No disclosure or conflicts. Outline
Advances in Cardiovascular Diagnosis and Therapy Firas Zahr, MD Assistant Professor of Medicine Interventional Cardiology University Of Iowa No disclosure or conflicts Outline What is new with revascularization?
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationPCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France
PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More information